IC
NUVB icon

Ikarian Capital’s Nuvation Bio NUVB Stock Holding History

Ikarian Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-619,258
Closed -$1.21M – 186
2025
Q2 		$1.21M Hold
619,258
– – 0.23% 78
2025
Q1 		$1.09M Buy
619,258
+535,851
+642% +$1.22M 0.13% 95
2024
Q4 		$222K Buy
83,407
+125
+0.2% +$322 0.03% 149
2024
Q3 		$191K Sell
83,282
-275,000
-77% -$839K 0.03% 138
2024
Q2 		$1.05M Sell
358,282
-275,000
-43% -$839K 0.18% 75
2024
Q1 		$2.31M Sell
633,282
-589,570
-48% -$1.13M 0.25% 82
2023
Q4 		$1.85M Hold
1,222,852
– – 0.17% 87
2023
Q3 		$1.64M Buy
+1,222,852
New +$2.04M 0.2% 82
2022
Q2 		– Sell
-213,310
Closed -$1.12M – 182
2022
Q1 		$1.12M Buy
213,310
+13,310
+7% +$74.8K 0.15% 94
2021
Q4 		$1.7M Buy
+200,000
New +$1.84M 0.25% 73
2021
Q2 		– Sell
-250,000
Closed -$2.61M – 260
2021
Q1 		$2.61M Buy
250,000
+48,192
+24% +$539K 0.09% 183
2020
Q4 		$2.36M Buy
+201,808
New +$2.1M 0.1% 144

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Ikarian Capital's NUVB Position: Q3 2025 in Review

Ikarian Capital sold out of Nuvation Bio (NUVB) in Q3 2025, closing a stake of 619,258 shares — an estimated $1.21M sold.

Ikarian Capital first reported a position in NUVB in Q4 2020 and held it in 12 quarters. The position peaked at $2.61M in Q1 2021. 203 funds tracked by Wall St. Rank hold NUVB as of Q3 2025.

  • Ikarian Capital reported no remaining Nuvation Bio position as of Q3 2025 after selling out during the quarter.
  • Ikarian Capital sold 619,258 Nuvation Bio shares in Q3 2025, an estimated $1.21M.
  • Ikarian Capital first reported a position in Nuvation Bio in Q4 2020 and held it in 12 quarters.
  • Ikarian Capital's Nuvation Bio position peaked at $2.61M in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2025.

Based on Ikarian Capital's 13F filing for Q3 2025, filed 14 Nov 2025.